Channel Title: Radius Research Channel Description: Great access to CEOs and new companies. Institutional Quality. <video> NeuPath Health (NPTH) Joe Walewicz CEO of Canada's largest chronic pain management services provider Description: NeuPath Health(NPTH) CEO Joe Walewicz discusses Neupath's large organic and acquisition growth opportunities. Canada's largest provider of pain management The company continues to grow and expand margins through optimization, acquisitions and additional value-added services CEO Joe Walewicz discusses Neupath's large organic and acquisition growth opportunities. The company continues to grow and expand margins through optimization, acquisitions and additional value-added services. NeuPath operates a growing network of healthcare clinics and related businesses in Ontario and Alberta focused on improved access to care and outcomes for patients by leveraging best-in-class treatments and delivering patient-centered multidisciplinary care. The medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. In addition, NeuPath provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. www.neupath.com. This video is produced on behalf of the presenting company NEUPATH HEALTH INC. @NeuPathHealth $NPTH #NPTH #neupathhealth #chronicpainmanagement #acupuncturerelief #chronicpainsolutions #healthcare #wellness CEO Joseph Walewicz "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" NEUPATH HEALTH INC. @NeuPathHealth $NPTH #NPTH #neupathhealth #chronicpainmanagement #acupuncturerelief #chronicpainsolutions #healthcare #wellness NPTH Stock Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Progressive Planet (PLAN) Record Q2/F2025 Earnings & Strong Cashflow - CEO Steve Harpur Description: Dec. 4, 2024 /CNW/ - Progressive Planet Solutions Inc. (TSXV: PLAN) (OTCQB: ASHXF) ("Progressive Planet", "PLAN", or the "Company") is pleased to announce its financial results for its second quarter ending on October 31, 2024. The Company's implementation of its cost cutting plan beginning in late fiscal 2023, and its parallel focus on transitioning to higher-margin products, have contributed to a significant improvement in profitability during the second quarter, as compared to the prior year's second quarter. "In fiscal 2024, we focused on cost controls and positioning for long-term growth. This strategy paid off with a standout second quarter, driven by higher-margin products and disciplined execution. These record profits reflect our team's dedication to delivering sustainable shareholder value. I couldn't be prouder of what our team has achieved—and this is just the beginning.," stated Steve Harpur, CEO. "Progressive Planet, a manufacturing company operating out of Kamloops, British Columbia, is reimagining what is possible when we prioritize our planet’s health. Our expertise lies in developing products using our owned mineral assets and recycled materials to create Products for a Healthy Planet™. Our C-Quester™ Centre of Sustainable Solutions is proudly disrupting the cement, agricultural and animal care industries. Our product lines include patented and patent pending products which are developed with the express intent of promoting a healthy planet using naturally occurring minerals and the urban mining of recycled materials. Our products are found in over 10,000 retail stores across North America." This video is produced on behalf of the presenting company PROGRESSIVE PLANET SOLUTIONS @progressiveplan $PLAN $PLAN.V #PLAN #cleantech #sustainable #sustainability #esg #wastemanagementsolutions #buildingsolutions CEO Steve Harpur "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" PROGRESSIVE PLANET SOLUTIONS @progressiveplan $PLAN $PLAN.V #PLAN #cleantech #sustainable #sustainability #esg #wastemanagementsolutions #buildingsolutions PLAN Stock Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Satellos Bioscience (MSCL) CEO Frank Gleeson: Phase 1 & 2 Milestones for 2024-2025 targeting DMD Description: CEO Frank Gleeson and CFO Elizabeth Williams discuss Satellos' novel treatment technology targeting degenerative muscle diseases. Satellos applies its proprietary discovery platform MyoReGenX™ to identify muscle diseases and disorders where muscle tissue is lost or muscle regeneration is defective. The phase 1 clinical trial of SAT-3247 targeting Duchenne Muscular Dystrophy (DMD) has started. Satellos is a publicly traded biotechnology company dedicated to developing life-improving medicines to treat degenerative muscle diseases. Satellos has incorporated breakthrough research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX TM , to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, Satellos is building a pipeline of novel therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in clinical development as a potential disease-modifying treatment for Duchenne muscular dystrophy. Satellos is headquartered in Toronto, Ontario. For more information, visit www.satellos.com . Targeting Degenerative Muscle Diseases This video is produced on behalf of the presenting company. https://satellos.com/ SATELLOS BIOSCIENCE INC. "@SatellosBio " $MSCL MSCL Stock #MSCL #satellosbioscience #duchenne #musculardystrophy #bioscience #disease #muscleregeneration #dmd #stemcell "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Rakovina Therapeutics (RKV) Exec Chair Jeffery Bacha: A.I. powered drug discovery with out-licensing Description: Executive Chairman Jeffery Bacha discusses Rakovina's novel low-cost drug development and partnering strategy targeting DNA-damage response inhibitors. Rakovina Therapeutics Inc. is focused on the development of new cancer treatments based on novel DNA-damage response technologies. The company has established a pipeline of novel DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials and obtaining marketing approval for new cancer therapeutics from Health Canada, the United States Food and Drug Administration, and similar international regulatory agencies. Further information may be found at www.rakovinatherapeutics.com. This video is produced on behalf of the presenting company RAKOVINA THERAPEUTICS INC. @rakovina_rkv $RKV #RKV #CancerResearch #DNAResponse #CancerTreatment #OncologyInnovation #Biotech #CancerTherapeutics Executive Chairman Jeffrey Bacha "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" RAKOVINA THERAPEUTICS INC. @rakovina_rkv $RKV #RKV #CancerResearch #DNAResponse #CancerTreatment #OncologyInnovation #Biotech #CancerTherapeutics RKV Stock Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Wedgemount Resources (WDGY) CEO Mark Vanry: Innovative Low Cap-Ex & Lo-Risk Growth Model Description: CEO Mark Vanry discusses the innovative growth plan using enhanced recovery techniques to acquire and grow Permian Basin assets. Wedgemont has just completed a substantial acquisition of additional west-central Texas oil assets which includes 20,000 acres of 37 oil & gas leases, including 111 producing wells. "Wedgemount Resources is a junior oil & gas company focused on maximizing shareholder value through the acquisition, development and exploitation of natural resource projects in the southern USA. " This video is produced on behalf of the presenting company WEDGEMOUNT RESOURCES CORP. @wedgemountres $WDGY $WDGRF #WDGY #WDGRF #wedgemountresources #oil #oilandgas #energy CEO Mark Vanry "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" WEDGEMOUNT RESOURCES CORP. @wedgemountres $WDGY $WDGRF #WDGY #WDGRF #wedgemountresources #oil #oilandgas #energy WDGY Stock Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> MustGrow Biologics (MGRO) CEO Corey Giasson give update on commercialization & global partnerships Description: CEO Corey Giasson and COO Colin Bletsky will be presenting an update and taking questions from the audience. Mustgrow is an agriculture biotech company developing organic Biocontrol, Soil Amendment and Biofertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply and help farmers feed the world. Mustgrow and its leading global partners -- Janssen PMP (pharmaceutical division of Johnson & Johnson), Bayer, Sumitomo Corporation, and Univar Solutions' NexusBioAg -- are developing mustard-based organic solutions to potentially replace harmful synthetic chemicals. Over 150 independent tests have been completed, validating Mustgrow's safe and effective approach to crop and food protection, and yield and soil improvements. This video is produced on behalf of the presenting company MUSTGROW BIOLOGICS @MustGrowBio $MGRO $MGROF $0C0 #MGRO #agriculture #biotech #AG #agritech #sustainability #cropprotection CEO Corey Giasson COO Colin Bletsky "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" MUSTGROW BIOLOGICS @MustGrowBio $MGRO $MGROF $0C0 #MGRO #agriculture #biotech #AG #agritech #sustainability #cropprotection MGRO Stock Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Odd Burger (ODD) High-Growth Food Technology Company - CEO James McInnes Description: CEO James McInnes is highlighting Odd Burger's vegan food technology, consumer product distribution and franchise restaurant growth strategy. The company is on the cusp of expanding into the US market with it's no-capex low-risk franchise model. Odd Burger Corporation is a franchised vegan fast-food restaurant chain and food technology company that manufactures a proprietary line of plant-based protein and dairy alternatives. Its manufactured products are distributed to Odd Burger restaurant locations through its foodservice line and also sold at grocery retailers through its consumer-packaged goods (CPG) line. Odd Burger restaurants operate as smart kitchens, which use state-of-the art cooking technology and automation solutions to deliver a delicious food experience to customers craving healthier and more sustainable fast food. With small store footprints optimized for delivery and takeout, advanced cooking technology, competitive pricing, a vertically integrated supply chain along with healthier ingredients, Odd Burger is revolutionizing the fast-food industry by creating guilt-free fast food that can be enjoyed at its restaurant locations or at home though its CPG line. Odd Burger Corporation is traded on the TSX Venture Exchange under the symbol "ODD" and on the OTCQB under the symbol "ODDAF". For more information visit https://www.oddburger.com. This video is produced on behalf of the presenting company ODD BURGER CORPORATION @oddburger $ODD $GBLYF #oddburger #plantbased #plantbasedmeals #plantpowered #shopvegan #veganfood CEO James McInness "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" ODD BURGER CORPORATION @oddburger $ODD $GBLYF #oddburger #plantbased #plantbasedmeals #plantpowered #shopvegan #veganfood ODD Stock Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Hydrograph (HG) CEO Kjirstin Breure: update on commercialization and graphene development milestones Description: CEO Kjirstin Breure is providing an update on major commercialization progress and technological advancements on it's pristine graphene and other nano materials. "HydroGraph Clean Power Inc is a leading producer of pristine graphene using an “explosion synthesis” process, which allows for exceptional purity, low energy use and identical batches. The quality, performance and consistency of HydroGraph’s graphene follows the Graphene Council’s Verified Graphene Producer® standards, of which very few graphene producers are able to meet. For more information or to learn about the HydroGraph story, visit: https://hydrograph.com/. " This video is produced on behalf of the presenting company HYDROGRAPH CLEAN POWER @HydroGraphInc $HGCPF $HG #hydrograph #HG #graphene #nanomaterials #alternativeenergy #superconducting #conductivity #electronics CEO Kjirstin Breure "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" HYDROGRAPH CLEAN POWER @HydroGraphInc $HGCPF $HG #hydrograph #HG #graphene #nanomaterials #alternativeenergy #superconducting #conductivity #electronics HG Stock Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Rakovina Therapeutics (RKV) Exec Chairman Jeffrey Bacha discusses AI generated drug candidates Description: Rakovina Therapeutics Inc. has received initial results from the proprietary Deep Docking AI (artificial intelligence) platform. Rakovina employed the Deep Docking algorithm to evaluate billions of molecular structures to develop a short list of drug candidates that have been optimized to a specific target product profile. A screening effort of this magnitude would not be possible with traditional medicinal chemistry approaches. Rakovina Therapeutics Inc. is focused on the development of new cancer treatments based on novel DNA-damage response technologies. The company has established a pipeline of novel DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials and obtaining marketing approval for new cancer therapeutics from Health Canada, the United States Food and Drug Administration, and similar international regulatory agencies. Further information may be found at www.rakovinatherapeutics.com. Cancer Focused Drug Development This video is produced on behalf of the presenting company. www.rakovinatherapeutics.com RAKOVINA THERAPEUTICS INC. @rakovina_rkv $RKV RKV Stock #RKV #CancerResearch #DNAResponse #CancerTreatment #OncologyInnovation #Biotech #CancerTherapeutics "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Revolve Renewable Power (REVV) 608% Revenue Growth and $2.6 million earnings - CEO Steve Dalton Description: Revolve Renewable Power is a developer and operator of renewable power projects in the USA, Mexico and Canada. This video is produced on behalf of the presenting company. https://revolve-renewablepower.com/ REVOLVE RENEWABLE POWER (REVV) @PowerRevolve $REVV $REVV.V REVV Stock #REVV #renewablepower #batterystorage #renewableenergy #solarenergy #windenergy #esg #esginvesting #climateaction "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Geodrill (GEO) Solid Q3-2024 Financial Results - Growth and Recovery Continue - CEO Dave Harper Description: Geodrill is a drilling services company for the mining industry operating in West Africa, Egypt and South America Geodrill has been successful in establishing a leading market position in Ghana and Ivory Coast. The company also operates in other African jurisdictions, including Egypt and Senegal, and is expanding its geographic presence in the South America countries of Chile and Peru. With the largest fleet of multi-purpose rigs, Geodrill provides a broad selection of diverse drilling services, including exploration, delineation, underground and grade control drilling, to meet the specific needs of its clients. The company's client mix is made up of senior mining, intermediate and junior exploration companies. Drilling Services Company providing services in west Africa, Egypt, and Peru. This video is produced on behalf of the presenting company. https://www.geodrill-gh.com/ GEODRILL "@Geodrill_GH " $GEO $GEO.DF GEO Stock #drilling #exploration #development #drillingservices #mining #africa #GEO #GEODF "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Nova Leap Health (NLH) Another Solid Q3 Results - CEO Chris Dobbin on the quarter and acquisitions Description: CEO Chris Dobbin discusses Nova Leap Health's Q3 2024 quarterly results and the recently announced acquisitions. Nova Leap is an acquisitive home health care services company operating in one of the fastest-growing industries in the United States and Canada. The company performs a vital role within the continuum of care with an individual- and family-centred focus, particularly those requiring dementia care. The company is geographically diversified with operations in numerous U.S. regions including New England, Southeastern, South-Central and Midwest regions as well as in Nova Scotia, Canada. Home Health Care Services This video is produced on behalf of the presenting company. https://novaleaphealth.com/ NOVA LEAP HEALTH N/A $NLH NLH Stock #NLH #novaleap #healthcare #homehealthcare #dementia "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Revolve Renewable Power (REVV) CEO Myke Clark and CFO Tania Ontiveros Review Q1/F25 Results + Update Description: CEO Myke Clark and CFO Tania Ontiveros Review Q1/F25 Results and the recent announcement of the completion of a Major Interconnection Milestone on the 49.6MW Primus Wind Project. November 27, 2024 / Revolve Renewable Power Corp. (TSXV:REVV)(OTCQB:REVVF), a North American owner, operator and developer of renewable energy projects, reported its financial results for the three months ended September 30, 2024 (Q1 FY2025). This earnings release should be read in conjunction with the Company's consolidated financial statements and management's discussion and analysis, which are available on the Company's website at www.revolve-renewablepower.com and have been posted on SEDAR+ at www.sedarplus.ca. December 3, 2024 / Revolve Renewable Power Corp. (TSXV:REVV)(OTCQB:REVVF), a North American owner, operator and developer of renewable energy projects, is pleased to announce the completion of a significant milestone for its 49.6-megawatt ("MW") Primus Wind Project located in Colorado, USA (the "Primus Wind Project"). Specifically, Revolve completed the interconnection process for the Primus Wind Project and has signed an interconnection agreement with Tri-State Generation and Transmission Inc. ("Tri State"). Completion of this milestone paves the way for the Project to complete the remaining permitting works with a target of being "ready to build" (or "RTB") in late 2025. Revolve Renewable Power is a developer and operator of renewable power projects in the USA, Mexico and Canada. This video is produced on behalf of the presenting company. https://revolve-renewablepower.com/ REVOLVE RENEWABLE POWER (REVV) @PowerRevolve $REVV $REVV.V REVV Stock #REVV #renewablepower #batterystorage #renewableenergy #solarenergy #windenergy #esg #esginvesting #climateaction "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> MustGrow Biologics (MGRO) Proposed Acquisition of NexusBioAg - CEO Corey Giasson & COO Colin Bletsky Description: MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0)announced the signing of a non-binding term-sheet (the “Term Sheet“) dated November 27, 2024 with Univar Solutions Canada Ltd. (“Univar Solutions“) for the proposed acquisition of certain assets that represent NexusBioAg. Mustgrow is an agriculture biotech company developing organic Biocontrol, Soil Amendment and Biofertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply and help farmers feed the world. Mustgrow and its leading global partners -- Janssen PMP (pharmaceutical division of Johnson & Johnson), Bayer, Sumitomo Corporation, and Univar Solutions' NexusBioAg -- are developing mustard-based organic solutions to potentially replace harmful synthetic chemicals. Over 150 independent tests have been completed, validating Mustgrow's safe and effective approach to crop and food protection, and yield and soil improvements. This video is produced on behalf of the presenting company MUSTGROW BIOLOGICS @MustGrowBio $MGRO $MGROF $0C0 #MGRO #agriculture #biotech #AG #agritech #sustainability #cropprotection CEO Corey Giasson COO Colin Bletsky "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" MUSTGROW BIOLOGICS @MustGrowBio $MGRO $MGROF $0C0 #MGRO #agriculture #biotech #AG #agritech #sustainability #cropprotection MGRO Stock Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video> <video> Star Royalties (STRR) CIO Kevin MacLean: Proposed Acquisition of Sabre Gold by Minera Alamos Description: Star Royalties Ltd. is a carbon credit and precious metals royalty and streaming company, with joint venture with Agnico Eagle Mines and Cenovus Energy. The Company innovated the world’s first carbon credit royalties in forestry and regenerative agriculture through its pure-green joint venture, Green Star Royalties Ltd., and offers investors exposure to carbon credit and precious metals prices. This video is produced on behalf of the presenting company STAR ROYALTIES LTD. @StarRoyalties $STRR $STRFF $STRR.V #STRR #starroyalties #carboncredits #naturebasedsolutions #carbonsequestration #preciousmetals CEO Alex Pernin VP BD Dmitry Kushnir "Please subscribe to The Radius Research Channel if you like these videos and help bring more interviews with high quality companies and CEOs. Register here to receive my weekly small-cap & venture cap newsletter with live webinar registration for CEO Q&A. - https://lp.constantcontactpages.com/su/KHhowOK" STAR ROYALTIES LTD. @StarRoyalties $STRR $STRFF $STRR.V #STRR #starroyalties #carboncredits #naturebasedsolutions #carbonsequestration #preciousmetals STRR Stock Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers. </video>

Contacts and Links

Description

Great access to CEOs and new companies. Institutional Quality.

Videos from channel